G. Wu

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.

B. Han, G. Jiang, H. Pan, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of Mindray BC‐3600 hematology analyzer in a university hospital

G. Wu, G. Shu, H. Lu, 2013, International journal of laboratory hematology.

Parotid Gland Metastasis of Nasopharyngeal Carcinoma: Case Report and Review of the Literature

G. Wu, S. Zhang, X. Dong, 2009, The Journal of international medical research.

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B

M. Buti, P. Marcellin, R. Idilman, 2016, Alimentary pharmacology & therapeutics.

Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines.

G. Wu, Y. Zhou, R. Meng, 2015, Indian journal of cancer.

PO-077: Cetuximab Plus Radiotherapy for Chinese Patients with Locally Advanced Head and Neck Cancer

G. Wu, L. Gao, C. Xie, 2013 .

ID:1882 Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3

Ying Cheng, H. Wakelee, T. Mok, 2020 .

Population Bioequivalence (PBE) Statistical Method to Evaluate Particle Size Distri- bution of Unilamellar Liposomes Constructed by Microfluidic Chip

G. Wu, J. Shi, J. Li, 2020 .

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.

B. Han, G. Jiang, H. Pan, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Rebiopsy in patients with or without prior TKIs revealed complicated histology of lung cancer.

G. Wu, Qianwen Li, R. Meng, 2019, Journal of Clinical Oncology.